Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immunoglobulin Light-chain Amyloidosis × Whole-Body Irradiation × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 40 Myelodysplastic Syndromes 31 Precursor Cell Lymphoblastic Leukemia-Lymphoma 30 Hematologic Neoplasms 21 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 19 Leukemia, Biphenotypic, Acute 17 Leukemia, Lymphocytic, Chronic, B-Cell 16 Myeloproliferative Disorders 15 Hodgkin Disease 15 Leukemia, Myelomonocytic, Chronic 14 Leukemia 13 Multiple Myeloma 12 Lymphoma, Non-Hodgkin 12 Anemia, Refractory, with Excess of Blasts 12 Primary Myelofibrosis 9 Lymphoma 9 Burkitt Lymphoma 9 Lymphoma, Follicular 8 Lymphoma, Mantle-Cell 7 Lymphoma, B-Cell, Marginal Zone 7 Anemia, Aplastic 7 Neoplasms, Plasma Cell 6 Lymphoma, T-Cell 6 Leukemia, Prolymphocytic 6 Leukemia, Myeloid 6 Graft vs Host Disease 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Polycythemia Vera 4 Neoplasms 4 Leukemia, Myeloid, Accelerated Phase 4

Interventions

Dexamethasone 11 daratumumab 6 Bortezomib 6 Cyclophosphamide 5 venetoclax 3 ixazomib 3 belantamab mafodotin 3 Specimen Handling 3 Focal Adhesion Protein-Tyrosine Kinases 3 Calcium Dobesilate 3 pomalidomide 2 dexamethasone acetate 2 dexamethasone 21-phosphate 2 auricularum 2 X-Rays 2 Polymerase Chain Reaction 2 Phantoms, Imaging 2 Magnetic Resonance Spectroscopy 2 Clinical Protocols 2 Biopsy 2 4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 2 siltuximab 1 isatuximab 1 Valganciclovir 1 Therapeutics 1 Stem Cell Transplantation 1 Spectrometry, Fluorescence 1 Positron-Emission Tomography 1 Pharmaceutical Preparations 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡